01Cycle & ovaries
Where it starts.
Disrupted LH and FSH signaling. Anovulation. The arrested follicles that ultrasound used to call cysts.
- Irregular or absent periods
- Anovulation, partway eggs that stall
- Difficulty conceiving without support
- Heavy or painful periods when they arrive
- Severe PMS or full PMDD
Deep dive →02Metabolism
The engine behind most symptoms.
Up to 70% of women with PMOS have insulin resistance. It runs almost everything else.
- Insulin resistance, elevated fasting insulin
- Stubborn weight, especially around the middle
- 3pm energy crashes
- Sugar and carb cravings that feel hormonal
- Bloat, slow digestion, slow muscle gain
Deep dive →03Endocrine
The full hormone web.
The 'Polyendocrine' in PMOS is doing real work. Ovaries, adrenals, thyroid, hypothalamus, pituitary. All in the loop.
- Elevated testosterone, DHEA-S, DHT
- Suppressed SHBG
- Elevated LH to FSH ratio
- Higher rates of subclinical hypothyroidism
- Disrupted cortisol rhythm
04Skin & hair
The visible side.
Excess androgens reach sebaceous glands and hair follicles. The earliest, loudest sign.
- Hormonal acne on jaw, chin, neck
- Scalp thinning
- Hirsutism on face, chest, stomach
- Oily and dull at the same time
- Acanthosis nigricans (dark velvety patches)
Deep dive →05Mood
Mood is a hormone problem too.
Women with PMOS have around 3x the risk of anxiety and depression. Inflammation, insulin, and hormone fluctuations all play a part.
- Higher rates of anxiety and depression
- Brain fog, especially mid cycle
- Mood swings around anovulatory cycles
- Disrupted sleep, including sleep apnoea
- Higher rates of disordered eating
06Gut
The microbiome is in the loop.
The gut shifts in PMOS, then feeds back into insulin and androgens. Older PCOS frameworks missed this entirely.
- Reduced microbial diversity
- Increased intestinal permeability
- Chronic low grade inflammation
- High overlap with IBS symptoms
- Bidirectional gut to ovary signaling
07Long term
Why this is worth catching early.
The metabolic and cardiovascular risks are exactly why the medical community pushed for the rename.
- ~4x lifetime risk of type 2 diabetes
- Higher risk of non alcoholic fatty liver
- Higher rates of dyslipidaemia and hypertension
- Increased cardiovascular risk later in life
- Higher risk of endometrial hyperplasia